Literature DB >> 15034938

Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells.

Hak Jun Ahn1, Yeong Shik Kim, Joung-Uk Kim, Sung Min Han, Jin Woo Shin, Hyun Ok Yang.   

Abstract

Taxol is extensively used clinically for chemotherapy of patients with ovarian, breast, and lung cancer. Although taxol induces apoptosis of cancer cells, its exact mechanism of action is not yet known. To determine the mechanism of action of taxol in ovarian cancer, we tested the effects of the drug, on the human ovarian carcinoma cell line, SKOV3. We observed that taxol-induced apoptosis of these cells by phosphatidylserine (PS) externalization and DNA fragmentation. While treatment of cells with taxol resulted in bcl-2 phosphorylation and mitochondrial depolarization, cytochrome c was not released and pro-caspase-3 was not activated. Treatment of SKOV3 cells with taxol, however, resulted in the translocation of AIF from the mitochondria to the nucleus via the cytosol. Taken together, these findings suggest that in SKOV3 cells, taxol induces caspase-independent AIF-dependent apoptosis. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034938     DOI: 10.1002/jcb.20006

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death.

Authors:  Jennifer Nelson; Elizabeth Gibbons; Katalyn R Pickett; Michael Streeter; Ashley O Warcup; Celestine H-Y Yeung; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2011-04-12

2.  Lead optimization of dual tubulin and Hsp27 inhibitors.

Authors:  Bo Zhong; Rati Lama; Daniel G Kulman; Bibo Li; Bin Su
Journal:  Eur J Med Chem       Date:  2014-04-13       Impact factor: 6.514

3.  Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma.

Authors:  Ying-Jen Jeffrey Wu; Alexander J Neuwelt; Leslie L Muldoon; Edward A Neuwelt
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

4.  Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.

Authors:  Kenji Ishitsuka; Teru Hideshima; Makoto Hamasaki; Noopur Raje; Shaji Kumar; Hiromasa Hideshima; Norihiko Shiraishi; Hiroshi Yasui; Aldo M Roccaro; Paul Richardson; Klaus Podar; Steven Le Gouill; Dharminder Chauhan; Kazuo Tamura; Jack Arbiser; Kenneth C Anderson
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

5.  Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo.

Authors:  Kai-Da Wu; Young Shin Cho; Jonathan Katz; Vladimir Ponomarev; Selina Chen-Kiang; Samuel J Danishefsky; Malcolm A S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-19       Impact factor: 11.205

6.  Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells.

Authors:  Lizhou Jia; Shiwu Zhang; Yanfen Ye; Xin Li; Imelda Mercado-Uribe; Robert C Bast; Jinsong Liu
Journal:  Cancer Lett       Date:  2012-08-15       Impact factor: 8.679

7.  Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.

Authors:  Vaikunth Cuchelkar; Pavla Kopecková; Jindrich Kopecek
Journal:  Mol Pharm       Date:  2008-09-04       Impact factor: 4.939

Review 8.  Discovery and development of the epothilones : a novel class of antineoplastic drugs.

Authors:  Hans Reichenbach; Gerhard Höfle
Journal:  Drugs R D       Date:  2008

9.  Selective toxicity of rose bengal to ovarian cancer cells in vitro.

Authors:  Steven B Koevary
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-06-25

10.  Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.

Authors:  Su Huang; Travis W Day; Mi-Ran Choi; Ahmad R Safa
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.